Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bevilacqua Research Corporation (BRC) is a service-disabled veteran-owned small business (SDVOSB) based in Huntsville, Alabama, specializing in the intersection of artificial intelligence, cognitive science, and biomedical engineering. Founded in 1992 by Dr. Andrew Bevilacqua, the company has established a significant presence in the defense and aerospace sectors, providing advanced R&D and technical services to agencies such as the Department of Defense and NASA. BRC is particularly noted for its proprietary CORE (Cognitive Object Reasoning Engine) platform and its patented 'Optically Stimulated Cognitive Load Reduction' technology, which aims to treat neurodegenerative conditions like Parkinson's disease and enhance human performance in high-stress environments. The company is an active member of the Medical Technology Enterprise Consortium (MTEC) and collaborates with the Navy Experimental Dive Unit on biomedical research. By bridging military-grade AI with clinical health applications, BRC positions itself as a unique player in the emerging field of cognitive technology and neuro-rehabilitation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bevilacqua Research.